Chen XW, Guo XC, Cheng F. Impact of nutritional support on immunity, nutrition, inflammation, and outcomes in elderly gastric cancer patients after surgery. World J Gastrointest Surg 2024; 16(7): 2175-2182 [PMID: 39087092 DOI: 10.4240/wjgs.v16.i7.2175]
Corresponding Author of This Article
Fen Cheng, BM BCh, Nurse, Department of Gastroenterology, The First People’s Hospital of Jiangxia District, No. 1 Wenhua Avenue, Jiangxia District, Wuhan 430200, Hubei Province, China. cfen987@163.com
Research Domain of This Article
Medicine, Research & Experimental
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2175-2182 Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2175
Table 1 Comparison of basic characteristics of patients in the two groups, n (%)
Feature
Nutritional support group (n = 60)
Control group (n = 60)
P value
Age
75.2 ± 3.1
74.8 ± 3.5
0.412
Gender: Male/female
32/28
30/30
0.754
Pathological type
Adenocarcinoma
50 (83.3)
48 (80.0)
0.623
Mucinous adenocarcinoma
7 (11.7)
9 (15.0)
0.521
Other
3 (5.0)
3 (5.0)
1.000
Surgical approach
Radical resection
55 (91.7)
56 (93.3)
0.654
Gastrectomy
5 (8.3)
4 (6.7)
0.754
Table 2 Change trends of immune function indicators
Time point
Percentage of CD4+ lymphocytes in nutritional support group
Percentage of CD4+ lymphocytes in control group
CD4+/CD8+ ratio in nutritional support group
CD4+/CD8+ ratio in control group
Immunoglobulin G (g/L) in nutritional support group
Immunoglobulin G (g/L) in control group
Z value
P value
2 wk after surgery
35.2 ± 4.5
35.1 ± 4.7
1.2 ± 0.2
1.1 ± 0.1
10.5 ± 2.3
10.8 ± 2.1
2.37
< 0.05
4 wk after surgery
38.7 ± 4.2
37.8 ± 4.1
1.4 ± 0.3
1.3 ± 0.2
12.1 ± 2.5
11.5 ± 2.3
2.74
< 0.05
6 wk after surgery
39.8 ± 5.2
32.6 ± 4.2
1.5 ± 0.3
1.1 ± 0.2
15.2 ± 2.7
12.5 ± 2.4
3.14
< 0.05
Table 3 Trends in nutritional status
Time point
Weight (kg) in nutritional support group
Weight (kg) in control group
BMI in nutritional support group
BMI in control group
Z value
P value
2 wk after surgery
65.8 ± 3.5
66.1 ± 3.2
24.5 ± 1.8
24.7 ± 1.7
1.53
< 0.05
4 wk after surgery
66.1 ± 3.7
64.8 ± 3.5
24.8 ± 1.9
24.2 ± 1.8
-3.27
< 0.05
6 wk after surgery
66.2 ± 3.8
64.5 ± 3.4
24.9 ± 2.0
23.8 ± 1.9
-1.43
< 0.05
Table 4 Change trends of inflammatory response indicators
Time point
C-reactive protein (mg/L) in nutritional support group
C-reactive protein (mg/L) in control group
White blood cell count (× 109/L) in nutritional support group
White blood cell count (× 109/L) in control group
Z value
P value
2 wk after surgery
3.2 ± 0.8
3.1 ± 0.7
6.2 ± 1.1
6.1 ± 1.0
2.25
< 0.05
4 wk after surgery
3.4 ± 1.0
3.6 ± 0.9
6.3 ± 1.2
6.8 ± 1.1
-2.53
< 0.05
6 wk after surgery
3.5 ± 1.0
4.0 ± 1.2
6.5 ± 1.3
7.2 ± 1.2
1.52
< 0.05
Table 5 Trends in clinical outcomes
Time point
Length of stay (d) in nutritional support group
Length of stay (d) in control group
Infection rate (%) in nutritional support group
Infection rate (%) in control group
Z value
P value
2 wk after surgery
10.5 ± 2.3
11.8 ± 2.5
15.0%
22.5%
2.11
< 0.05
4 wk after surgery
9.1 ± 1.8
10.7 ± 2.1
12.5%
18.3%
-2.74
< 0.05
6 wk after surgery
8.3 ± 1.8
12.2 ± 2.7
10.0%
25.0%
1.63
< 0.05
Citation: Chen XW, Guo XC, Cheng F. Impact of nutritional support on immunity, nutrition, inflammation, and outcomes in elderly gastric cancer patients after surgery. World J Gastrointest Surg 2024; 16(7): 2175-2182